Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study

BACKGROUND: Diabetic macular oedema (DMO) is the leading cause of sight impairment in working age populations in developed countries. Current first line treatment for centre-involving DMO involves intravitreal anti-VEGF but treatment response can be variable. In this retrospective, real world, multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Sing Yue, Ghulakhszian, Arevik, Minocha, Amal, Ramcharan, Dhannie, Nokhostin, Soroush, Cheong-Leen, Richard, George, Sheena, Posner, Esther, Dinah, Christiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144175/
https://www.ncbi.nlm.nih.gov/pubmed/34045845
http://dx.doi.org/10.2147/OPTH.S314614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144175/
https://www.ncbi.nlm.nih.gov/pubmed/34045845
http://dx.doi.org/10.2147/OPTH.S314614

Ejemplares similares